Physician profile
Michael Robert Boland
NPI 1962414078
$24,036.60
in general payments reported to CMS, 2019-2025
26 companies · $5,049 in 2025
The $5,049 reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,133 · 2020: $2,502 · 2021: $1,085 · 2022: $4,413 · 2023: $4,079 · 2024: $4,775 · 2025: $5,049.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,895 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,750 · Grant: $3,500 · Travel and Lodging: $1,009 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,894.68 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,750.00 |
| Grant | $3,500.00 |
| Travel and Lodging | $1,008.95 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,783.82 | 2023-2025 | Lumigan, Alphagan P |
| Allergan, INC. | $3,780.19 | 2019-2022 | |
| Glaukos Corporation | $3,484.24 | 2022-2025 | Kxl System (Not Refurbished), Travoprost Intraocular Implant - Idose, Istent Infinite |
| Coopervision INC. | $2,308.46 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Biotissue Holdings INC. | $1,845.19 | 2020-2025 | |
| Bausch & Lomb Americas INC. | $1,319.07 | 2022-2025 | Miebo, Xiidra, Infuse |
| Sun Pharmaceutical Industries INC. | $1,274.67 | 2019-2025 | Cequa |
| Alcon Vision LLC | $1,138.58 | 2019-2025 | Total30, Precision7, Eysuvis |
| Aerie Pharmaceuticals, INC. | $1,000.00 | 2019 | |
| Kala Pharmaceuticals, INC. | $520.04 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $364.62 | 2019-2022 | |
| Oyster Point Pharma, INC. | $315.67 | 2022-2025 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $279.36 | 2025 | Xdemvy |
| Lkc Technologies, INC. | $217.40 | 2024-2025 | |
| Dompe US, INC. | $212.12 | 2023-2025 | Oxervate |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $203.20 | 2022-2025 | Acuvue |
| Ocular Therapeutix, INC. | $185.60 | 2022-2024 | Dextenza |
| Merz North America, INC. | $154.54 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $144.14 | 2025 | Tecnis Iol |
| Topcon Healthcare, INC. | $135.61 | 2021 | |
| Quidel Corporation | $124.94 | 2019-2022 | |
| Mallinckrodt Enterprises LLC | $121.97 | 2019 | |
| Thea Pharma INC. | $34.50 | 2025 | Iyuzeh |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $32.10 | 2019-2021 | |
| Ortho-Clinical Diagnostics, INC. | $29.00 | 2024 | |
| Shire North American Group INC | $27.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Boland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.